SCHEMBL6405768

SCHEMBL6405768

CCOCCSc1nnc(-c2ccc(OC(F)(F)F)cc2)[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 1/20 0.38
SCN10A Q9Y5Y9 7/20 0.38
KCNH2 Q12809 4/20 0.35
SCN9A Q15858 2/20 0.35
SCN1A P35498 1/20 0.35
SCN5A Q14524 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN8A Q9UQD0 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CACNA2D1 P54289 1/20 0.34
KIF11 P52732 1/20 0.34
NPY5R Q15761 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6406053 0.81 MEN1 (0.39) KDM4EALDH1A1MEN1LMNAMAPT
SCHEMBL16171132 0.77 GRK6 (0.49) GRK6SCN10AKCNH2SCN9ASCN1A
SCHEMBL6404365 0.77 GRK6 (0.40) GRK6SCN10AKCNH2SCN9ASCN1A
SCHEMBL6408622 0.76 GRK6 (0.62) GRK6SCN10ASCN9AKDM4EMAPT
SCHEMBL6411809 0.76 GRK6 (0.40) GRK6SCN10AKCNH2SCN9ASCN1A
SCHEMBL6404070 0.75 SCN9A (0.49) GRK6SCN10ASCN9ALMNAMAPT
SCHEMBL6411081 0.70 SCN9A (0.47) GRK6SCN9AKDM4EALDH1A1MEN1
SCHEMBL6407548 0.69 CYP2C9 (0.52) KDM4EALDH1A1MAPTHTT
SCHEMBL25260119 0.69 SCN10A (0.47) GRK6SCN10AKCNH2SCN9ASCN1A
SCHEMBL10171990 0.68 SCN10A (0.45) GRK6SCN10AKCNH2SCN9ASCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT GRK6 3937/4885SCN10A 4775/4885KCNH2 2873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.